Column Capital Advisors, LLC Karyopharm Therapeutics Inc. Transaction History
Column Capital Advisors, LLC
- $1.92 Billion
- Q3 2023
Shares
2 transactions
Others Institutions Holding KPTI
# of Institutions
120Shares Held
72.4MCall Options Held
476KPut Options Held
175K-
Black Rock Inc. New York, NY9.45MShares$7.84 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.34MShares$6.92 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX8.3MShares$6.89 Million0.48% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$4.23 Million0.9% of portfolio
-
Eversept Partners, LP New York, NY5.02MShares$4.16 Million0.57% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $66.2M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...